A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis
Clinical trial NCT04973137 · TERMINATED
Trial details
- NCT number
- NCT04973137
- Sponsor
- Prothena Biosciences Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2025-04-02
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.